International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
International Journal of Stroke shared a post on X about a recent article, by Sohei Yoshimura, published in SAGE Publishing, adding:
”Study finds oral anticoagulant alone and DOAC with antiplatelet therapy were associated with higher risks of major bleeding events than single antiplatelet therapy.”
Title: Long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular disease
Authors: Sohei Yoshimura, Kaori Miwa, Masatoshi Koga, Kanta Tanaka, Yoshiki Yagita, Yoshinari Nagakane, Haruhiko Hoshino, Tadashi Terasaki, Masayuki Shiozawa, Yasuyuki Iguchi, Shuji Arakawa, Shigeru Fujimoto, Yasushi Okada, Masafumi Ihara, Shinichi Takahashi, Ryosuke Doijiri, Makoto Sasaki, Yusuke Yakushiji, Teruyuki Hirano, Kazunori Toyoda
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding
-
May 13, 2026, 15:10Wolfgang Miesbach: Rethinking Bleeding Risk in Anticoagulation
-
May 13, 2026, 15:09Veronica Sanchez: Better Cardiovascular Health Helps Lower Heart Attack Risk
-
May 13, 2026, 15:07Tung Nguyen Thanh: New Perspective on Thrombosis in Hematological Malignancies in Vietnam
-
May 13, 2026, 15:03Haji Siyamuddin Ansari: The Key Difference Between Plasma and Serum
-
May 13, 2026, 14:45Masoabi Sefojane: The Cost of a 35-Year Diagnosis Delay
-
May 13, 2026, 14:39Ahmed Mohsen: Managing DVT During Pregnancy and Lactation
-
May 13, 2026, 14:38The Coffee Shop Origins of Factor V Leiden – ISTH
-
May 13, 2026, 14:33Moustafa Abdou: Could a Commonly Prescribed Drug Trigger Life-Threatening Hemolysis?